Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor EGFR Mutant Non-Small Cell Lung Cancer NSCLC
A Multi-Center Phase II Study of Ipatasertib in Combination with Docetaxel in Metastatic/Advanced NSCLC Patients Who Have Failed or Are Intolerant to 1st Line Immunotherapy
Study Type: Treatment
Phase: II
NCTID: NCT04467801
Principal Investigator:
Jun Zhang
Phase II, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin ABBV-399 in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer
Study Type: Treatment
Phase: II
NCTID: NCT03539536
Principal Investigator:
Jun Zhang
A Randomized Phase II Trial of Hypo-fractionated Intensity-Modulated Radiation Therapy IMRT Utilizing 2.5 Gy/Fraction VS. Standard-Fractionated IMRT, Concurrent with Carboplatin/Paclitaxel and Followed by Consolidation Durvalumab, for Subjects with Stage III Non-Small Cell Lung Cancer
Study Type: Treatment
Phase: II
NCTID: NCT04992780
Principal Investigator:
Krishna Reddy
Phase III, Open-Label, Randomized Study of Lazertinib with Subcutaneous Amivantamab Administered via Manual Injection Compared with Intravenous Amivantamab or Subcutaneous Amivantamab Administered via On Body Delivery System in Patients with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy PALOMA-3.
Study Type: Treatment
Phase: III
NCTID: NCT05388669
Principal Investigator:
Jun Zhang
A Randomized, Open-Label, Phase II Study of Canakinumab or Pembrolizumab As Monotherapy or in Combination as Neoadjuvant Therapy in Subjects with Resectable Non-Small Cell Lung Cancer CANOPY-N
Study Type: Treatment
Phase: II
NCTID: NCT03968419
Principal Investigator:
Jun Zhang